cbdMD, Inc. (YCBD-PA)

USD 0.68

(1.49%)

Gross Profit Summary of cbdMD, Inc.

cbdMD, Inc.'s latest annual gross profit in 2023 was 14.97 Million USD , down -32.95% from previous year.
cbdMD, Inc.'s latest quarterly gross profit in 2024 Q3 was 3.11 Million USD , up 31.88% from previous quarter.
cbdMD, Inc. reported a annual gross profit of 22.33 Million USD in annual gross profit 2022, down -25.51% from previous year.
cbdMD, Inc. reported a annual gross profit of 29.98 Million USD in annual gross profit 2021, up 13.72% from previous year.
cbdMD, Inc. reported a quarterly gross profit of 2.58 Million USD for 2024 Q2, down -21.17% from previous quarter.
cbdMD, Inc. reported a quarterly gross profit of 3.11 Million USD for 2024 Q3, up 31.88% from previous quarter.

Annual Gross Profit Chart of cbdMD, Inc. (2023 - 2016)

Historical Annual Gross Profit of cbdMD, Inc. (2023 - 2016)

Year	Gross Profit	Gross Profit Growth
2023	14.97 Million USD	-32.95%
2022	22.33 Million USD	-25.51%
2021	29.98 Million USD	13.72%
2020	26.36 Million USD	81.67%
2019	14.51 Million USD	152.57%
2018	5.74 Million USD	84.22%
2017	3.11 Million USD	655.11%
2016	413.13 Thousand USD	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	3.27 Million USD	-7.75%
2024 Q2	2.58 Million USD	-21.17%
2024 Q3	3.11 Million USD	31.88%
2023 Q4	3.54 Million USD	-7.72%
2023 Q3	3.84 Million USD	-4.23%
2023 FY	14.97 Million USD	-32.95%
2023 Q1	3.56 Million USD	-28.2%
2023 Q2	4.01 Million USD	12.55%
2022 Q2	6.44 Million USD	29.01%
2022 Q4	4.96 Million USD	-16.24%
2022 FY	22.33 Million USD	-25.51%
2022 Q1	4.99 Million USD	-13.04%
2022 Q3	5.93 Million USD	-7.91%
2021 Q1	8.89 Million USD	39.78%
2021 Q2	8.15 Million USD	-8.35%
2021 FY	29.98 Million USD	13.72%
2021 Q4	5.74 Million USD	-20.13%
2021 Q3	7.18 Million USD	-11.84%
2020 Q2	6.66 Million USD	3.4%
2020 Q1	6.44 Million USD	25.61%
2020 FY	26.36 Million USD	81.67%
2020 Q4	6.36 Million USD	-7.59%
2020 Q3	6.88 Million USD	3.32%
2019 Q1	757.84 Thousand USD	18.7%
2019 FY	14.51 Million USD	152.57%
2019 Q4	5.13 Million USD	0.94%
2019 Q3	5.08 Million USD	43.7%
2019 Q2	3.53 Million USD	366.94%
2018 Q1	459.63 Thousand USD	-15.93%
2018 Q2	2.55 Million USD	456.33%
2018 Q3	2.09 Million USD	-18.2%
2018 Q4	638.42 Thousand USD	-69.48%
2018 FY	5.74 Million USD	84.22%
2017 FY	3.11 Million USD	655.11%
2017 Q1	37.09 Thousand USD	126.64%
2017 Q2	1.01 Million USD	2623.44%
2017 Q3	1.52 Million USD	51.03%
2017 Q4	546.74 Thousand USD	-64.16%
2016 Q3	64.14 Thousand USD	0.0%
2016 Q4	-139.24 Thousand USD	-317.07%
2016 FY	413.13 Thousand USD	0.0%

Peer Gross Profit Comparison of cbdMD, Inc.

Name	Gross Profit	Gross Profit Difference
China Pharma Holdings, Inc.	-504.88 Thousand USD	3066.572%
cbdMD, Inc.	14.97 Million USD	0.0%
Zomedica Corp.	17.31 Million USD	13.514%